Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
By Dennis Thompson HealthDay Reporter THURSDAY, Oct. 24, 2024 (HealthDay News) -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.
Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study
In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes.
2d
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...
19h
on MSN
Tens of thousands to be recruited into Alzheimer’s trials after landmark drug rejected
Tens of thousands of people will be recruited into Alzheimer’s trials after a landmark drug was rejected for use on the NHS.
19h
New Diagnostic Blood Test For Alzheimer’s Disease Targets Tau
A newly published study from Sweden unveiled a blood test capable of detecting Alzheimer’s disease with 90% accuracy.
15h
on MSN
Alzheimer's Link with Gut Health Revealed by New Study
Certain bacteria in the gut might increase the risk of developing Alzheimer's disease, a recent mouse study has found.
Medical News Today
1d
Semaglutide drugs may help keep Alzheimer's at bay
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
8h
on MSN
Walk to End Alzheimer’s this Saturday
LYNCHBURG, Va. (WDBJ) - In Lynchburg, The Alzheimer’s Association is asking the community to walk together this weekend. The ...
2d
on MSN
Neuroscientists Reveal New Alzheimer's 'Brain Maintenance' Skill
Researchers have used advanced brain-imaging techniques to determine whether language skills physically alters the brain's ...
21h
on MSN
New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.View on ...
16h
on MSN
Walk to End Alzheimer's in Tyler this weekend to raise funds for research efforts
The Alzheimer's Association is hosting the Walk to End Alzheimer’s in Tyler Saturday at UT Tyler Patriot Plaza starting at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ozempic
Novo Nordisk
National Health Service
Eli Lilly
Wegovy
Feedback